IT1194281B - Derivati di piridazinoni impiegabili come sostanze medicinali e procedimento per la loro fabricazione - Google Patents

Derivati di piridazinoni impiegabili come sostanze medicinali e procedimento per la loro fabricazione

Info

Publication number
IT1194281B
IT1194281B IT8321684A IT2168483A IT1194281B IT 1194281 B IT1194281 B IT 1194281B IT 8321684 A IT8321684 A IT 8321684A IT 2168483 A IT2168483 A IT 2168483A IT 1194281 B IT1194281 B IT 1194281B
Authority
IT
Italy
Prior art keywords
procedure
manufacture
medicinal substances
pyridazinone derivatives
pyridazinone
Prior art date
Application number
IT8321684A
Other languages
English (en)
Other versions
IT8321684A0 (it
Inventor
Henri Chibret
Original Assignee
Thea Therapeutique & Applicat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Therapeutique & Applicat filed Critical Thea Therapeutique & Applicat
Publication of IT8321684A0 publication Critical patent/IT8321684A0/it
Application granted granted Critical
Publication of IT1194281B publication Critical patent/IT1194281B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT8321684A 1982-06-18 1983-06-17 Derivati di piridazinoni impiegabili come sostanze medicinali e procedimento per la loro fabricazione IT1194281B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8210630A FR2528837A1 (fr) 1982-06-18 1982-06-18 Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication

Publications (2)

Publication Number Publication Date
IT8321684A0 IT8321684A0 (it) 1983-06-17
IT1194281B true IT1194281B (it) 1988-09-14

Family

ID=9275129

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8321684A IT1194281B (it) 1982-06-18 1983-06-17 Derivati di piridazinoni impiegabili come sostanze medicinali e procedimento per la loro fabricazione

Country Status (10)

Country Link
JP (1) JPS5910571A (it)
KR (1) KR860001339B1 (it)
BE (1) BE897085A (it)
CH (1) CH657125B (it)
DE (1) DE3321772A1 (it)
FR (1) FR2528837A1 (it)
GB (1) GB2122195A (it)
GR (1) GR78284B (it)
IT (1) IT1194281B (it)
NL (1) NL8302087A (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666902A (en) * 1983-06-20 1987-05-19 Cassella Aktiengesellschaft Tetrahydropyridazinone derivatives, processes for their preparation and their use
EP0210530A1 (de) * 1985-07-27 1987-02-04 MERCK PATENT GmbH 6-Arylalkenylpyridazinone
JPS63220512A (ja) * 1987-03-09 1988-09-13 松下電器産業株式会社 電解コンデンサ用電極箔
JPH04100106U (it) * 1991-02-12 1992-08-28
JPH0776050B2 (ja) * 1991-07-25 1995-08-16 実 近藤 ワークの移送装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2304977A1 (de) * 1973-02-01 1974-08-08 Basf Ag Neue dihydropyridazinone

Also Published As

Publication number Publication date
FR2528837A1 (fr) 1983-12-23
JPS5910571A (ja) 1984-01-20
GR78284B (it) 1984-09-26
IT8321684A0 (it) 1983-06-17
GB2122195A (en) 1984-01-11
CH657125B (it) 1986-08-15
FR2528837B1 (it) 1984-12-07
GB8316516D0 (en) 1983-07-20
KR860001339B1 (ko) 1986-09-15
NL8302087A (nl) 1984-01-16
BE897085A (fr) 1983-12-19
DE3321772A1 (de) 1983-12-22
KR840005105A (ko) 1984-11-03

Similar Documents

Publication Publication Date Title
IT1153437B (it) Derivati 5-amminometil-ossazolidinici, procedimento per la loro preparazione, e loro applicazione in terapia
IT1170286B (it) Derivati del labdano, procedimento per la loro preparazione, e composizioni farmaceutiche contenenti derivati del labdano
IT1140040B (it) Derivati di nor-tropano e granatano, loro procedimento di preparazione e loro applicazione in terapia
IT1168074B (it) Derivati amminoalchil-eterociclici, loro procedimento di preparazione e loro applicazione in terapia
IT8567757A0 (it) Derivati di benzonorbornene procedimento per la loro preparazione e composizioni medicinali e cosmetiche che li contengono
IT1172149B (it) Derivati del benzopirano e del benzotiopirano loro preparazione e loro impiego come medicamenti
IT1156490B (it) Derivati carbostirilici procedimento per la loro preparazione e composizioni carditoniche contenenti tali derivati
IT1121483B (it) Derivati di benzotiepinici e procedimento per la loro preparazione
IT1175924B (it) Cefem derivati e procedimenti per la loro preparazione
IT1129933B (it) Derivati tioetilammidici loro composizioni farmaceutiche e procedimento per la loro preparazione
IT1195267B (it) Derivati teofillinmetildiossolanici,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1200944B (it) Derivati xantinici,procedimento per la loro preparazione,composizione farmaceutiche che il contengono e loro impiego terapeutico
IT1185828B (it) Derivati del calcone e procedimento per la loro preparazione
IT8148952A0 (it) Amminoglucosidi ammidinati procedimento per loro preparazione e loro impiego come medicamenti
IT8348309A0 (it) Derivati del 2(hi)-piridinone, loro preparazione e loro impiego come medicamenti
IT1194281B (it) Derivati di piridazinoni impiegabili come sostanze medicinali e procedimento per la loro fabricazione
IT1164180B (it) Derivati n-carbammoilici dell'isotiazolo-(5,4b)piridin-one-3 e loro procedimento di preparazione
IT8148859A0 (it) Derivati del 3-amminopropossibenze ne loro preparazione e loro impiegocome medicamenti
IT8320278A0 (it) Derivati delle rifamicine eprocedimento per la loro preparazione.
IT1157126B (it) N(vinblastin-23-il)derivati di aminoacidi loro preparazione ed applicazione terapeutica
IT8024151A0 (it) Derivati di 10-alo-e-omoeburnano eprocedimento per la loro preparazione.
IT1153293B (it) Derivati del 4-idrossi-2-metil-2h-1, 2-benzotiazina-3-carbossamide 1, 1-biossido e procedimento per la loro preparazione
IT1164175B (it) Nuovi derivati sostituiti del tiamorfolinone e loro procedimenti di preparazione
IT1163943B (it) Derivati 15-cicloalifatici di 13,14-dideidro carboprostacicline e procedimento per la loro preparazione
IT1151104B (it) Impiego terapeutico di derivati (1-cinnamoil oppure 1-fenetil-carbonil)piperazinici